ARTICLE | Company News
AstraZeneca, Teva inflammation, pulmonary news
September 15, 2014 7:00 AM UTC
The U.K. High Court ruled that AstraZeneca's European Patent No. 1,085,877 related to the pharma's Symbicort budesonide/formoterol for asthma and chronic obstructive pulmonary disease (COPD) was obvi...